Data / Drug companies / Omeprazole
Omeprazole: 106 companies and 324 products in the FDA NDC directory
Omeprazole is listed in the FDA National Drug Code Directory by 106 companies, with 324 products in commercial distribution. 249 of the products (76.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, delayed release; tablet, delayed release; tablet, orally disintegrating, delayed release, and the newest product started marketing on October 23, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 106
- Products
- 324
- Generic (ANDA) products
- 249 (76.9%)
- Application numbers
- 24
- Routes
- Oral
- Brand names
- Acid Reducer, DG Health Omperazole
- openFDA record search
- api.fda.gov
Companies that list omeprazole
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 21 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | March 25, 2020 |
| Bryant Ranch Prepack | 12 | capsule, delayed release | Generic drugs (ANDA) | July 1, 2019 |
| Aphena Pharma Solutions - Tennessee, LLC | 10 | capsule, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | December 27, 2024 |
| NuCare Pharmaceuticals,Inc. | 10 | capsule, delayed release | Generic drugs (ANDA) | June 3, 2022 |
| Amazon.com Services LLC | 8 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | September 11, 2026 |
| Walgreen Company | 8 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | March 6, 2026 |
| Advanced Rx of Tennessee, LLC | 6 | capsule, delayed release | Generic drugs (ANDA) | March 6, 2025 |
| Dr. Reddy's Laboratories Limited | 6 | capsule, delayed release | Generic drugs (ANDA) | March 1, 2014 |
| Golden State Medical Supply, Inc. | 6 | capsule, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | December 27, 2024 |
| Kroger Company | 6 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | May 5, 2025 |
| Preferred Pharmaceuticals Inc. | 6 | capsule, delayed release | Generic drugs (ANDA) | April 21, 2026 |
| Proficient Rx LP | 6 | capsule, delayed release | Generic drugs (ANDA) | October 31, 2014 |
| L. Perrigo Company | 5 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | May 7, 2026 |
| Safeway | 5 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | April 27, 2026 |
| Sandoz Inc | 5 | capsule, delayed release | Generic drugs (ANDA) | July 1, 2019 |
| Amerisource Bergen | 4 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | September 11, 2019 |
| Apotex Corp. | 4 | capsule, delayed release | Generic drugs (ANDA) | January 21, 2009 |
| Aurohealth LLC | 4 | tablet, delayed release; capsule, delayed release | Generic drugs (ANDA) | April 28, 2023 |
| Chain Drug Marketing Association, Inc. | 4 | tablet, delayed release; capsule, delayed release | Generic drugs (ANDA) | October 23, 2026 |
| Dolgencorp, Inc. (dollar General & Rexall) | 4 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | June 8, 2022 |
| H E B | 4 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | July 1, 2026 |
| NorthStar Rx LLC | 4 | capsule, delayed release | Generic drugs (ANDA) | March 1, 2026 |
| PLD Acquisitions LLC DBA Avma Pharma Solutions | 4 | tablet, delayed release | Generic drugs (ANDA) | October 31, 2024 |
| Proficient Rx LP | 4 | capsule, delayed release | Generic drugs (ANDA) | July 1, 2019 |
| Proficient Rx LP | 4 | capsule, delayed release | Generic drugs (ANDA) | February 20, 2019 |
| QPharma, Inc. | 4 | capsule, delayed release | Generic drugs (ANDA) | July 1, 2019 |
| Remedyrepack Inc. | 4 | capsule, delayed release | Generic drugs (ANDA) | September 18, 2024 |
| St. Mary's Medical Park Pharmacy | 4 | capsule, delayed release | Generic drugs (ANDA) | March 2, 2026 |
| Strategic Sourcing Services LLC | 4 | tablet, delayed release | New drug applications (NDA) | November 20, 2024 |
| Target Corporation | 4 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | February 3, 2022 |
| American Sales Company | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | March 11, 2021 |
| Asclemed USA, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | October 31, 2014 |
| Aurobindo Pharma Limited | 3 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2015 |
| CVS Pharmacy | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | March 28, 2022 |
| Cardinal Health 110, LLC. DBA Leader | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | April 16, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 3 | capsule, delayed release | Generic drugs (ANDA) | October 31, 2014 |
| Hawaii Repack, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | October 31, 2014 |
| HyVee Inc | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | January 28, 2026 |
| Innovus Pharmaceuticals, Inc. | 3 | tablet, delayed release; capsule, delayed release | Generic drugs (ANDA) | May 25, 2023 |
| Lannett Company, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | January 23, 2009 |
| Meijer Distribution Inc | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | March 13, 2018 |
| Meijer, Inc. | 3 | capsule; tablet, delayed release | Generic drugs (ANDA) | January 29, 2026 |
| Northwind Health Company, LLC | 3 | capsule, delayed release | Generic drugs (ANDA) | September 26, 2022 |
| P & L Development, LLC | 3 | tablet, delayed release | Generic drugs (ANDA) | August 29, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | March 1, 2014 |
| Quallent Pharmaceuticals Health LLC | 3 | capsule, delayed release | Generic drugs (ANDA) | November 15, 2025 |
| Rising Pharma Holdings, Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2015 |
| Topco Associates LLC | 3 | tablet, delayed release; tablet, orally disintegrating, delayed release | New drug applications (NDA) | April 2, 2018 |
| Wal-Mart Stores Inc | 3 | tablet, delayed release | New drug applications (NDA) | June 6, 2018 |
| Walmart Inc. | 3 | tablet, delayed release | Generic drugs (ANDA) | April 30, 2025 |
| Xiromed, LLC | 3 | capsule, delayed release | Generic drugs (ANDA) | January 30, 2025 |
| Zydus Lifesciences Limited | 3 | capsule, delayed release | Generic drugs (ANDA) | November 23, 2012 |
| Zydus Pharmaceuticals USA Inc. | 3 | capsule, delayed release | Generic drugs (ANDA) | November 23, 2012 |
| American Health Packaging | 2 | capsule, delayed release | Generic drugs (ANDA) | December 1, 2025 |
| Bi-Mart | 2 | tablet, delayed release | Generic drugs (ANDA) | September 30, 2019 |
| Bjwc | 2 | tablet, orally disintegrating, delayed release; tablet, delayed release | New drug applications (NDA) | March 9, 2020 |
| CVS Pharmacy | 2 | tablet, delayed release | New drug applications (NDA) | March 27, 2015 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | capsule, delayed release | Generic drugs (ANDA) | February 6, 2026 |
| Camber Pharmaceuticals, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | September 26, 2019 |
| Chartwell RX, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | September 3, 2003 |
| Discount Drug Mart | 2 | tablet, delayed release | Generic drugs (ANDA) | September 1, 2026 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | October 1, 2020 |
| Family Dollar (family Wellness) | 2 | tablet, delayed release | Generic drugs (ANDA) | February 28, 2025 |
| H E B | 2 | capsule, delayed release; tablet, delayed release | Generic drugs (ANDA) | August 7, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | capsule, delayed release | Generic drugs (ANDA) | February 20, 2019 |
| Northwind Health Company, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | June 6, 2025 |
| Phoenix RX LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | March 6, 2025 |
| Publix Super Markets Inc | 2 | tablet, delayed release | New drug applications (NDA) | July 1, 2022 |
| Redpharm Drug | 2 | tablet, delayed release; capsule, delayed release | Generic drugs (ANDA) | June 1, 2019 |
| Rugby Laboratories | 2 | tablet, delayed release | Generic drugs (ANDA) | April 15, 2025 |
| Sam's West Inc | 2 | tablet, delayed release | New drug applications (NDA) | February 7, 2024 |
| Strides Pharma Science Limited | 2 | powder, for suspension | Generic drugs (ANDA) | October 1, 2022 |
| United Natural Foods, Inc. DBA Unfi | 2 | tablet, orally disintegrating, delayed release; tablet, delayed release | New drug applications (NDA) | October 11, 2018 |
| Valu Merchandisers Company | 2 | tablet, delayed release | Generic drugs (ANDA) | July 20, 2018 |
| WinCo Foods, LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | January 15, 2026 |
| 7-Eleven | 1 | tablet, delayed release | Generic drugs (ANDA) | June 6, 2018 |
| Allegiant Health | 1 | tablet, delayed release | Generic drugs (ANDA) | March 21, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | January 23, 2009 |
| Army and Air Force Exchange Service | 1 | tablet, delayed release | New drug applications (NDA) | October 28, 2008 |
| AvPAK | 1 | capsule, delayed release | Generic drugs (ANDA) | March 22, 2023 |
| BluePoint Laboratories | 1 | tablet, delayed release | Generic drugs (ANDA) | June 19, 2020 |
| Boswell Pharmacy Services LLC D/B/A BPS Wholesale | 1 | capsule, delayed release | Generic drugs (ANDA) | June 12, 2024 |
| Bryant Ranch Prepack | 1 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2015 |
| Camber Consumer Care Inc | 1 | tablet, delayed release | Generic drugs (ANDA) | March 25, 2020 |
| Cardinal Health 107, LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | November 23, 2012 |
| Costco Wholesale Company | 1 | tablet, delayed release | New drug applications (NDA) | February 27, 2008 |
| Coupler LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | January 29, 2025 |
| Fred's, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | June 6, 2018 |
| Geri-Care Pharmaceuticals, Corp | 1 | tablet, delayed release | Generic drugs (ANDA) | May 23, 2024 |
| Gobrands, Inc | 1 | tablet, delayed release | New drug applications (NDA) | July 21, 2023 |
| H2-Pharma, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | August 4, 2026 |
| Harris Teeter | 1 | tablet, delayed release | Generic drugs (ANDA) | September 16, 2020 |
| Little Pharma, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | July 15, 2020 |
| Major Pharmaceuticals | 1 | capsule, delayed release | Generic drugs (ANDA) | November 23, 2012 |
| Northeast Pharma | 1 | tablet, delayed release | Generic drugs (ANDA) | July 5, 2021 |
| Ohm Laboratories Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | June 1, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | January 21, 2009 |
| Padagis Israel Pharmaceuticals Ltd | 1 | tablet, delayed release | New drug applications (NDA) | February 25, 2008 |
| Quality Care Products LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | October 13, 2010 |
| Reliable 1 Laboratories LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | March 11, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, delayed release | 183 | 56.5% |
| Tablet, delayed release | 117 | 36.1% |
| Tablet, orally disintegrating, delayed release | 18 | 5.6% |
| Capsule, delayed release pellets | 3 | 0.9% |
| Powder, for suspension | 2 | 0.6% |
| Capsule | 1 | 0.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 249 | 76.9% |
| New drug applications (NDA) | 75 | 23.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 324 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.